{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-11-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Eligible",
      "product_code": "PEF",
      "openfda": {},
      "review_panel": "HO",
      "medical_specialty": "HO",
      "device_name": "Heparin Flush In 0.45% Sodium Chloride",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "General Hospital",
      "device_class": "2",
      "definition": "The heparin flush in 0.45% sodium chloride is intended to maintain patency of an indwelling intravenous catheter device designed for intermittent injection or infusion therapy or blood sampling.  It provides an alternative to clinicians to prevent sodium overload in neonatal patients.",
      "regulation_number": "880.5200",
      "implant_flag": "N",
      "submission_type_id": "1"
    }
  ]
}